Search results
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 4 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
Diagnosing Psoriatic Arthritis for the Dermatologist
Medscape· 1 week agoEditor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...
Guselkumab Provides Long-Term Relief From PsA Symptoms
Medscape· 1 week agoGuselkumab improved joint swelling, spinal pain, skin symptoms, and overall disease activity in a...
Plaque psoriasis plagues Marietta man for over 30 years until new treatment
WAGA fox local articles via Yahoo News· 2 weeks agoGreg Morrison of Marietta has been struggling with plaque psoriasis and psoriatic arthritis for more than 30 years. Four months ago, ...
Salicylic acid for psoriasis: Benefits, risks, and uses
Medical News Today· 1 week agoSalicylic acid may reduce both the appearance and symptoms of psoriasis. It can exfoliate the skin ...
Supplements for Psoriasis: Which Ones Have Benefits or Risks?
Verywell Health via Yahoo News· 1 week agoSupplements that may help improve or manage psoriasis symptoms include oral supplements like vitamin...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 13 hours agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
Morningstar· 1 week agoFood and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe ...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 2 hours agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos, ...
FDA Approves Second Ustekinumab Biosimilar
Medscape· 1 week agoThe biosimilar is expected to be marketed in the United States on or after February 21, 2025.